DPH5
Basic information
Region (hg38): 1:100989623-101026088
Links
Phenotypes
GenCC
Source:
- neurodevelopmental disorder with short stature, prominent forehead, and feeding difficulties (Limited), mode of inheritance: AR
- neurodevelopmental disorder with short stature, prominent forehead, and feeding difficulties (Strong), mode of inheritance: AR
- neurodevelopmental disorder with short stature, prominent forehead, and feeding difficulties (Moderate), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Neurodevelopmental disorder with short stature, prominent forehead, and feeding difficulties | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic | 35482014 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (24 variants)
- Neurodevelopmental_disorder_with_short_stature,_prominent_forehead,_and_feeding_difficulties (9 variants)
- DPH5-related_diphthamide-deficiency_syndrome (2 variants)
- not_provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DPH5 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000015958.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 0 | |||||
| missense | 29 | 31 | ||||
| nonsense | 1 | |||||
| start loss | 0 | |||||
| frameshift | 1 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 2 | 1 | 30 | 0 | 0 |
Highest pathogenic variant AF is 0.000033472388
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| DPH5 | protein_coding | protein_coding | ENST00000370109 | 7 | 36466 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 8.11e-7 | 0.513 | 124756 | 0 | 41 | 124797 | 0.000164 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.481 | 131 | 147 | 0.888 | 0.00000662 | 1855 |
| Missense in Polyphen | 37 | 49.095 | 0.75364 | 636 | ||
| Synonymous | -0.358 | 56 | 52.7 | 1.06 | 0.00000253 | 547 |
| Loss of Function | 0.817 | 11 | 14.3 | 0.767 | 7.07e-7 | 184 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000187 | 0.000187 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000111 | 0.000111 |
| Finnish | 0.000139 | 0.000139 |
| European (Non-Finnish) | 0.000197 | 0.000194 |
| Middle Eastern | 0.000111 | 0.000111 |
| South Asian | 0.000203 | 0.000196 |
| Other | 0.000663 | 0.000660 |
dbNSFP
Source:
- Function
- FUNCTION: S-adenosyl-L-methionine-dependent methyltransferase that catalyzes four methylations of the modified target histidine residue in translation elongation factor 2 (EF-2), to form an intermediate called diphthine methyl ester. The four successive methylation reactions represent the second step of diphthamide biosynthesis. {ECO:0000250|UniProtKB:P32469, ECO:0000269|PubMed:23486472}.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Synthesis of diphthamide-EEF2;Gamma carboxylation, hypusine formation and arylsulfatase activation;diphthamide biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.102
Intolerance Scores
- loftool
- 0.437
- rvis_EVS
- 0.3
- rvis_percentile_EVS
- 72.01
Haploinsufficiency Scores
- pHI
- 0.548
- hipred
- Y
- hipred_score
- 0.731
- ghis
- 0.536
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.292
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dph5
- Phenotype
Gene ontology
- Biological process
- peptidyl-diphthamide biosynthetic process from peptidyl-histidine;methylation
- Cellular component
- cellular_component;cytosol
- Molecular function
- diphthine synthase activity